Dr. Mehmet Oz, the famous TV doctor-turned-politician, found himself in the hot seat today as he testified before the Senate Finance Committee in Washington, D.C. The high-profile hearing, centered on his nomination to lead the Centers for Medicare and Medicaid Services (CMS) under President Donald Trump, quickly turned into a battleground over taxes, privacy, and potential conflicts of interest.
If confirmed, Oz would take charge of health insurance programs impacting nearly 150 million Americans—including Medicare, Medicaid, and the Affordable Care Act.
“We have a generational opportunity to fix our healthcare system and help people stay healthy for longer,” Oz declared in his opening remarks. However, his vision for healthcare reform was soon overshadowed by a barrage of tough questions from skeptical lawmakers.
Financial Controversy and Ethical Concerns
Oz has come under fire for his financial ties to the healthcare and pharmaceutical industries, raising concerns about potential conflicts of interest. Senator Elizabeth Warren (D-MA) wasted no time calling for a full divestment from any holdings that could sway his decision-making at CMS.
Adding to the scrutiny, a memo from Senate Finance Committee Democratic staff accused Oz of underpaying Social Security and Medicare taxes between 2021 and 2023. The allegations, which suggest he avoided approximately $440,000 in taxes through a legal loophole, were met with fierce pushback from his spokesperson, who insisted Oz had complied with all ethical guidelines.
Fiery Exchange Over Medicaid and Patient Privacy
The hearing turned even more intense when Senator Ron Wyden (D-OR) directly challenged Oz on his tax practices.
“The doctor will testify about Medicare’s well-being, yet he is unwilling to pay the same taxes that millions of Americans pay out of their paychecks,” Wyden said, calling the alleged tax maneuvers “deeply concerning.”
Oz defended himself, emphasizing the importance of keeping Medicaid “viable at every level” and ensuring fair payments for doctors while maintaining patient access. But when pressed on whether he would rule out cuts to Medicaid, Oz’s response left room for interpretation, frustrating committee members.
The hearing also took an unexpected turn when Wyden raised concerns about Elon Musk’s Department of Government Efficiency (DOGE) and its potential access to Americans’ private medical records. Accusing the Trump administration of failing to address serious privacy issues, Wyden demanded answers. Oz, however, distanced himself from the matter, stating he had not been involved in discussions about DOGE but vowed to “address what is going on.”
Tense Moments and Heated Reactions
Later in the hearing, Senator Maggie Hassan (D-NH) posed a pointed question: “If directed by the president to take action that would break the law, would you follow the law or the president’s directive?”
Oz’s response was swift but controversial: “The president would never do that.”
Hassan, visibly unimpressed, shot back, “That’s absurd. And a disappointing answer.”
With the nomination process still unfolding, Dr. Oz faces mounting pressure to clarify his stance on these pressing issues. Whether he can overcome these hurdles and secure the CMS leadership role remains to be seen.
